Skip to main content
. Author manuscript; available in PMC: 2010 Apr 21.
Published in final edited form as: Am J Hematol. 2009 Feb;84(2):74–78. doi: 10.1002/ajh.21327

TABLE I.

Demographic and Clinical Characteristics of Participants According to VHL598C>T Status

Characteristics VHL wild type
(n = 32)
VHL598C>T
heterozygote (n = 4)
VHL598C>T
homozygote (n = 34)
P (homozygote vs.
wild type)
Male (%)a 15 (47%) 2 (50%) 12 (35%) 0.8
Age (years) 44 (15–50) 8 (6–13) 18 (13–51) 0.6
BMI (kg/m2) 20.6 (18.4–24.2) 14.7 (13.8–19.0) 19.6 (16.8–22.9) 0.3
History of smokinga 6 (19%) 0 (0%) 5 (15%) 0.7
History of alcohol consumptiona 2 (7%)b 0 (0%) 2 (7%)c 0.9
Systolic blood pressure (mmHg) 110 (102–120) 99 (93–112) 105 (95–116) 0.032
Diastolic blood pressure (mmHg) 72 (64–80) 65 (58–75) 69 (60–80) 0.3
Hemoglobin (g/dL) 13.7 (12.4–14.5) 14.4 (14.0–15.3) 18.6 (16.7–20.2) 0.0001
Hematocrit (%) 39.4 (36.2–43.1) 43.0 (40.7–44.2) 55.7 (51.8–59.2) 0.0001
MCV (ft) 90.1 (85.7–95.5) 85.5 (82.5–87.7) 87.6 (79.4–91.2) 0.051
White blood cell (103/mm3) 5.8 (5.2–6.7) 5.5 (5.0–8.1) 5.0 (4.3–5.8) 0.009
Platelets (103/mm3) 305 (247–355) 403 (369–444) 242 (178–322) 0.029
Lymphocyte% 37.3 (35.8–46.2) 49.3 (46.9–66.1) 44.0 (39.7–49.9) 0.2
Lymphocyte counts (103/mm3) 2.4 (1.9–2.8) 2.7 (2.4–5.5) 2.1 (1.8–2.6) 0.1

Results in median and interquartile range, unless otherwise specified.

a

Number (%).

b

N = 27.

c

N = 29.

HHS Vulnerability Disclosure